Worley Limited (ASX:WOR) handed investors a jarring full-year scorecard in August 2026, and the market's verdict was swift. The global engineering and professional-services group reported flat aggregated revenue, a double-digit fall in underlying Earnings and a statutory profit that shrank by more than a third. Yet beneath the headline profit slide sat a more complicated picture: bookings jumped, the sales pipeline expanded and the order Backlog actually grew over the year. The sell-off reflected a market recalibrating margins and near-term momentum rather than a wholesale loss of faith in the Demand story.

Latest Development

Worley released its results for the year ended 30 June 2026 before the market opened in August. Management framed the year as one of resilience against genuine external shocks. The escalation of conflict in the Middle East cost the Business roughly $58 million in earnings, while adverse foreign-exchange translation stripped out a further $50 million or so. Restructuring carried $120 million of one-off costs, though the company said it delivered $132 million of cost reductions against a $100 million target. The board maintained a final Dividend of 25 cents per share, unfranked, payable in late September 2026, and confirmed it had completed a $500 million buyback earlier in the year before launching a fresh $300 million programme.

Aggregated Revenue landed at $12,023 million, effectively flat on the prior year, or up 2.3 per cent to $12,325 million on a constant-currency basis. The earnings line is where the disappointment concentrated. Underlying EBITA fell 10.8 per cent to $734 million, or 6.1 per cent lower at $773 million in constant currency. Underlying NPATA declined 16.8 per cent to $395 million, while statutory NPATA dropped 35.6 per cent to $306 million as one-off items weighed on the bottom line.

The Margin story is nuanced and worth parsing carefully. On aggregated revenue including pass-through procurement, the underlying EBITA margin was 6.1 per cent, down from 6.8 per cent. Stripping out low-margin procurement --- the measure management steers by --- the margin held at 9.0 per cent, at the bottom of Worley's 9.0 to 9.5 per cent target band. Cash generation remained a genuine strength: normalised cash conversion of 93.6 per cent sat comfortably inside the 85 to 95 per cent target, gearing was a manageable 1.8 times, and the weighted average cost of Debt was 4.4 per cent.

By segment, Energy was the engine, contributing about $6.4 billion, or 53 per cent of revenue, and growing 8 per cent. Resources added roughly $3.3 billion, up 6 per cent. Chemicals was the clear soft spot, falling 22 per cent to around $2.4 billion as European project cancellations bit. Geographically, the Americas supplied 52 per cent of aggregated revenue and grew, while EMEA at 37 per cent absorbed the Middle East disruption.

The gap between a shrinking profit and an expanding order book sits at the heart of the market's discomfort. Contrary to a first-glance reading, Worley's backlog did not contract over the year. Reported backlog rose 9 per cent to $13.8 billion from $12.7 billion a year earlier, an increase of 18 per cent excluding currency effects. Bookings climbed 23 per cent to $15.5 billion, with 44 per cent sole-sourced, and the factored sales pipeline expanded 24 per cent, including 30 per cent growth in EPC and EPCM scopes and 49 per cent growth in future-facing markets.

The nuance investors seized on is sequential rather than annual. On a constant-currency basis the backlog measured about $15.0 billion, below the $16.9 billion peak struck at the end-of-2025 half-year mark. That step-down, combined with a softer margin and the earnings hit from geopolitics and currency, was enough to overwhelm the positive pipeline signals on the day. In short, the demand funnel is filling faster than the delivered backlog is converting, and the market chose to price the near-term earnings reality over the longer-dated growth optionality.

Bull Case

For longer-horizon investors, the operational signals are difficult to dismiss. A backlog up 9 per cent, bookings up 23 per cent and a pipeline up 24 per cent point to a demand environment that is broadening, not fading, with a substantial slice sole-sourced --- a proxy for pricing power and client stickiness. Roughly 62 per cent of the backlog is scheduled to convert within twelve months, offering reasonable near-term revenue visibility.

Cost discipline is also landing: $132 million of savings against a $100 million target shows the restructuring is doing more than absorbing charges. Cash conversion near 94 per cent, moderate gearing and an intact dividend give the Balance Sheet room to keep returning capital, evidenced by the back-to-back buybacks. Management's guidance for mid-to-high single-digit growth in both aggregated revenue and underlying EBITA in FY27, with margins broadly flat, signals confidence that the current-year drag is largely transitory. The strong lift in future-facing scopes keeps Worley aligned with structural spending on decarbonisation, grid infrastructure and low-carbon fuels.

Risks

The risks are equally concrete. Chemicals revenue fell 22 per cent, a reminder that European project cancellations can move the group's numbers materially and that the transition thesis is not immune to capital-cycle wobbles. Geopolitical exposure is a recurring feature rather than a one-off: the $58 million Middle East hit shows how quickly regional instability flows to earnings for a business with a heavy EMEA footprint.

Currency translation shaved tens of millions from reported results and could persist. The sequential slip in constant-currency backlog from the prior peak raises the question of whether that earlier level was a High-Water Mark or a pause. And with the margin on aggregated revenue slipping to 6.1 per cent, any failure to hold the ex-procurement margin inside the 9.0 to 9.5 per cent band would test the market's patience further. The unfranked dividend also limits after-tax appeal for some domestic income investors.

What Investors Should Watch Next

The clearest tell in the coming half will be book-to-bill and, critically, the conversion of that expanded pipeline into delivered, margin-accretive backlog rather than merely booked work. Watch whether constant-currency backlog stabilises or resumes climbing from the $15.0 billion level, and whether the future-facing scopes translate into revenue at group margins.

Margin trajectory is the second gauge: holding the 9.0 per cent ex-procurement figure and progressing back toward the top of the band would validate the cost programme. Investors should also track the FY27 guidance for signs of upgrade or slippage, the pace of the new $300 million buyback, Chemicals stabilisation, and any further geopolitical or FX shocks. On those measures, the FY27 half-year result due early in 2027 will be the next real test of whether the profit slide was a detour or a trend.